Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: ACTELION PHARMACEUTICALS US, INC.
Awarding agency: Department of Justice / Federal Prison System / Bureau of Prisons
Funding agency: Department of Justice / Federal Prison System / Bureau of Prisons
Period of performance: 2025-02-12 to 2025-02-17
Current total value of award: $35420.41
Description: MEDICATION USED TO TREAT PULMONARY HYPERTENSION FOR INMATE POPULATION.